IPCA Laboratories Limited (IPCALAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE571A01038
Key metrics
- Market Cap
- ₹49,566 Cr
- P/E Ratio
- 37.62
- EPS
- 51.93
- Book Value
- 375.4
- P/B Ratio
- 5.2
- ROE
- 11.98%
- ROCE
- 15.78%
- Debt / Equity
- 0.08
- Net Margin
- 11.93%
- Revenue Growth
- 8%
- Profit Growth
- 54.69%
- Dividend Yield
- 0.31%
- 52W High
- ₹1,992.00
- 52W Low
- ₹1,251.60
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About IPCA Laboratories Limited
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 17,210
- Promoter Holding
- 45.06%
The full IPCA Laboratories Limited analysis
Create a free account to open the complete IPCALAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.